Inside beenextTM, by owing more that twenty years experience in the MedChem field, he is involved in the Medicinal Chemistry as well the Custom Synthesis activities. Holding a MD in Chemistry (1991) at the Faculty of Chemistry of the University of Milan (Italy), he began his career at the Pharmacological Research. Inst. “Mario Negri” (Milan) moving then to the R&D department of Bracco Industria Chimica (Milan). Here as Team leader, he improve his scientifical training also by post-doctoral experience in Medicinal Chemistry (prof D.T. Witiak, Ohio State University and University of Wisconsin at Madison, USA). In the 1996, he became Assistant Professor in Medicinal Chemistry at the Faculty of Pharmacy of Novara (Italy), moving then to the Department of Science and Drug Technology (DSTF) of the University of Turin (UNITO) in the 2002. Since the beginning of his career, his major research interests have been focused on advanced organic synthesis, in particular on heterocyclic chemistry applied to Medicinal Chemistry. As PI his academic research at DSTF is currently directed to the development of small molecules active on Malaria, Cancer, Inflammation and Immunosuppression. For details about his academic activities see here. In the February 2013, Marco Lolli became scientific responsible of all the UNITO forces involved in TAKTIC, a 7FP-SME project called “TrAnslational Kinase Tumour Inhibitor discovery Consortium”. The TAKTIC consortium, where should be found international leaders both in academic and Small Medium Enterprise (SME) fields, was financed by EU with over 1.1M Euro / 24 months starting its works in February 2013.
Inside beenextTM, he is in charge of all the e-commerce activities and, by owing more that thirty years experience in Pharmaceutical Technology, he is involved in projects where nanotechnological drug deliveryprofiling is required. This work is usually done in close collaboration with the MedChem units. Holding a MD in Chemistry (1983) at the Faculty of Science M.F.N. of the University of Turin, in the 1991 became Assistant Professor in Technological Pharmaceutics at the Faculty of Pharmacy (Torino). Since 1995 is Associate Professor in Technological Pharmaceutics at the Department of Science and Drug Technology (DSTF) of the University of Turin (UNITO). Since the beginning of his career, his major research interests have been focused on Drug Delivery of Antitumor agents using Liposomal, Nanoparticles e Biotechnological approaches. His scientific work has culminated in more than 63 original articles in peer reviewed journals, several book chapters, three patents and more than 100 presentations at scientific meetings.
Inside beenextTM, by owing almost twenty years experience in Biochemistry, is responsible of the biochemical profiling on the small entity under investigation. This work is usually done in close collaboration with the MedChem units. Holding a MD in Chemistry and Drug Technologies (CTF, 1996) at the Faculty of Pharmacy of the University of Turin, in 1999 hold a Specialization at Hospital School of the University of Milano. She obtained her PhD in Bio-Chemical Sciences at the University of Turin in 2001. She improved his training also by PhD experience at Department of Biochemistry and Cell Biology at Rice University di Houston (Texas – USA) under the guidance of prof. Seiichi Matsuda. Since 2008, she is Assistant Professor in Biochemistry at Department of Science and Drug Technology (DSTF) of the University of Turin (UNITO). Her scientific work has culminated in more than 21 original articles in peer reviewed journals and more than 26 presentations at scientific meetings.
Inside beenextTM, due to his experience in the Finantial field, he is Chief Financial Officer (CFO) with responsibility for finance, human resources, administration and legal affairs. Holding in 1990 a MD in Economy and Commerce at the University of Parma, since that year he joined the Max Mara Fashion Group (1,3 mld euro of annual sales, 5000 employs, 105 countries). At the present, he is CSO at Diffusione Tessile srl, a company of the Max Mara Fashion Group with annual sales of EUR 100 million and employs approximately 600 employees. Since 2013 he is also in change of the web management of the whole Max Mara Fashion Group.
Arachno6xSR – Stopcock – click image to enlarge